1-12 of 12
Johannes Czernin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO-077: Study evaluating metastatic castrate resistant prostate cancer (mCRPC) treatment using 177Lu-PNT2002 PSMA therapy after second-line hormonal treatment (SPLASH) - Trial in progress

Kim N. Chi, Ur Metser, Johannes Czernin, Jeremie Calais, Vikas Prasad, Matthias Eiber, Neal Shore, Jessica Jensen, Neil Fleshner, Scott Tagawa, Oliver Sartor
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PO-077.
https://doi.org/10.1158/1557-3265.RADSCI21-PO-077
Published: 15 April 2021
View article titled, Abstract PO-077: Study evaluating metastatic castrate resistant prostate cancer (mCRPC) treatment using <sup>177</sup>Lu-PNT2002 PSMA therapy after second-line hormonal treatment (SPLASH) - Trial in progress
Journal Articles

Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity

Kyle Current, Catherine Meyer, Clara E. Magyar, Christine E. Mona, Joel Almajano, Roger Slavik, Andreea D. Stuparu, Chloe Cheng, David W. Dawson, Caius G. Radu, Johannes Czernin, Katharina Lueckerath
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12): 2946–2955.
https://doi.org/10.1158/1078-0432.CCR-19-1485
Published: 15 June 2020
View article titled, Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity
Open the PDF for Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity in another window
Includes: Supplementary data
Journal Articles

Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer

Wolfgang P. Fendler, Manuel Weber, Amir Iravani, Michael S. Hofman, Jérémie Calais, Johannes Czernin, Harun Ilhan, Fred Saad, Eric J. Small, Matthew R. Smith, Paola M. Perez, Thomas A. Hope, Isabel Rauscher, Anil Londhe, Angela Lopez-Gitlitz, Shinta Cheng, Tobias Maurer, Ken Herrmann, Matthias Eiber, Boris Hadaschik
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (24): 7448–7454.
https://doi.org/10.1158/1078-0432.CCR-19-1050
Published: 13 December 2019
View article titled, Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer
Open the PDF for Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy

Johannes Schwarzenberg, Johannes Czernin, Timothy F. Cloughesy, Benjamin M. Ellingson, Whitney B. Pope, Tristan Grogan, David Elashoff, Cheri Geist, Daniel H.S. Silverman, Michael E. Phelps, Wei Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (13): 3550–3559.
https://doi.org/10.1158/1078-0432.CCR-13-1440
Published: 30 June 2014
View article titled, Treatment Response Evaluation Using <sup>18</sup>F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy
Open the PDF for Treatment Response Evaluation Using <sup>18</sup>F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy in another window
Journal Articles

Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma

Thinle Chodon, Begoña Comin-Anduix, Bartosz Chmielowski, Richard C. Koya, Zhongqi Wu, Martin Auerbach, Charles Ng, Earl Avramis, Elizabeth Seja, Arturo Villanueva, Tara A. McCannel, Akira Ishiyama, Johannes Czernin, Caius G. Radu, Xiaoyan Wang, David W. Gjertson, Alistair J. Cochran, Kenneth Cornetta, Deborah J.L. Wong, Paula Kaplan-Lefko, Omid Hamid, Wolfram Samlowski, Peter A. Cohen, Gregory A. Daniels, Bijay Mukherji, Lili Yang, Jerome A. Zack, Donald B. Kohn, James R. Heath, John A. Glaspy, Owen N. Witte, David Baltimore, James S. Economou, Antoni Ribas
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (9): 2457–2465.
https://doi.org/10.1158/1078-0432.CCR-13-3017
Published: 30 April 2014
View article titled, Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
Open the PDF for Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

18F-FDG-PET/CT Imaging as an Early Survival Predictor in Patients with Primary High-Grade Soft Tissue Sarcomas Undergoing Neoadjuvant Therapy

Ken Herrmann, Matthias R. Benz, Johannes Czernin, Martin S. Allen-Auerbach, William D. Tap, Sarah M. Dry, Tibor Schuster, Jeff J. Eckardt, Michael E. Phelps, Wolfgang A. Weber, Fritz C. Eilber
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (7): 2024–2031.
https://doi.org/10.1158/1078-0432.CCR-11-2139
Published: 01 April 2012
View article titled, <sup>18</sup>F-FDG-PET/CT Imaging as an Early Survival Predictor in Patients with Primary High-Grade Soft Tissue Sarcomas Undergoing Neoadjuvant Therapy
Open the PDF for <sup>18</sup>F-FDG-PET/CT Imaging as an Early Survival Predictor in Patients with Primary High-Grade Soft Tissue Sarcomas Undergoing Neoadjuvant Therapy in another window
Journal Articles

Discriminant Analysis of 18F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma

Mirwais Wardak, Christiaan Schiepers, Magnus Dahlbom, Timothy Cloughesy, Wei Chen, Nagichettiar Satyamurthy, Johannes Czernin, Michael E. Phelps, Sung-Cheng Huang
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (20): 6553–6562.
https://doi.org/10.1158/1078-0432.CCR-10-3290
Published: 14 October 2011
View article titled, Discriminant Analysis of <sup>18</sup>F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma
Open the PDF for Discriminant Analysis of <sup>18</sup>F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma in another window
Includes: Multimedia, Supplementary data
Journal Articles

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas

Matthias R. Benz, Johannes Czernin, Martin S. Allen-Auerbach, William D. Tap, Sarah M. Dry, David Elashoff, Kira Chow, Vladimir Evilevitch, Jeff J. Eckardt, Michael E. Phelps, Wolfgang A. Weber, Fritz C. Eilber
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (8): 2856–2863.
https://doi.org/10.1158/1078-0432.CCR-08-2537
Published: 15 April 2009
View article titled, FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas
Open the PDF for FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas in another window
Journal Articles

Changes in Tumor Metabolism as Readout for Mammalian Target of Rapamycin Kinase Inhibition by Rapamycin in Glioblastoma

Liu Hua Wei, Helen Su, Isabel J. Hildebrandt, Michael E. Phelps, Johannes Czernin, Wolfgang A. Weber
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3416–3426.
https://doi.org/10.1158/1078-0432.CCR-07-1824
Published: 02 June 2008
View article titled, Changes in Tumor Metabolism as Readout for Mammalian Target of Rapamycin Kinase Inhibition by Rapamycin in Glioblastoma
Open the PDF for Changes in Tumor Metabolism as Readout for Mammalian Target of Rapamycin Kinase Inhibition by Rapamycin in Glioblastoma in another window
Journal Articles

Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas

Vladimir Evilevitch, Wolfgang A. Weber, William D. Tap, Martin Allen-Auerbach, Kira Chow, Scott D. Nelson, Fredrick R. Eilber, Jeffery J. Eckardt, Robert M. Elashoff, Michael E. Phelps, Johannes Czernin, Fritz C. Eilber
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 715–720.
https://doi.org/10.1158/1078-0432.CCR-07-1762
Published: 01 February 2008
View article titled, Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas
Open the PDF for Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas in another window
Journal Articles

Prognostic Significance of Fluorodeoxyglucose Uptake in Non–Small Cell Lung Cancer. A Blurry Picture?

Wolfgang A. Weber, Johannes Czernin, Michael E. Phelps
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (11): 3105–3106.
https://doi.org/10.1158/1078-0432.CCR-07-0188
Published: 01 June 2007
View article titled, Prognostic Significance of Fluorodeoxyglucose Uptake in Non–Small Cell Lung Cancer. A Blurry Picture?
Open the PDF for Prognostic Significance of Fluorodeoxyglucose Uptake in Non–Small Cell Lung Cancer. A Blurry Picture? in another window
Journal Articles

Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors

Helen Su, Claudia Bodenstein, Rebecca A. Dumont, Yann Seimbille, Steven Dubinett, Michael E. Phelps, Harvey Herschman, Johannes Czernin, Wolfgang Weber
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5659–5667.
https://doi.org/10.1158/1078-0432.CCR-06-0368
Published: 04 October 2006
View article titled, Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors
Open the PDF for Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors in another window